Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 7, Issue 2, 2007, Pages 135-144

  Tipoe, George L ^a   Leung, Tung Ming ^a   Hung, Ming Wai ^a   Fung, Man Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anti inflammation; Anti oxidant; Cardiovascular; Epigallocatechin gallate (EGCG); Oxidative stress; Reactive oxygen species

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BILIRUBIN; CASPASE 3; CYCLOOXYGENASE 2; CYTOCHROME C; CYTOKINE; EPIGALLOCATECHIN GALLATE; FREE RADICAL; GREEN TEA EXTRACT; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPID PEROXIDASE; MELATONIN; NITRIC OXIDE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; CARDIOVASCULAR DISEASE; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DNA DAMAGE; DRUG MECHANISM; DRUG PROTEIN BINDING; ENDOTHELIAL DYSFUNCTION; ENZYME INHIBITION; HEART PROTECTION; HUMAN; HYPERTENSION; HYPOXIA; INFLAMMATION; LIVER INJURY; NONHUMAN; NUTRITIONAL VALUE; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; SLEEP APNEA SYNDROME; UPREGULATION; VASODILATATION;

EID: 34347381789     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152907780830905     Document Type: Review

References (148)

1. Sheu, S. S.; Nauduri, D.; Anders, M. W. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim. Biophys. Acta 2006, 1762 (2), 256-265.
2. Starkov, A. A.; Fiskum, G.; Chinopoulos, C.; Lorenzo, B. J.; Browne, S. E.; Patel, M. S.; Beal, M. F. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 2004, 24 (36), 7779-7788.
3. Quinn, M. T.; Gauss, K. A. Structure and regulation of the neutrophil respiratory burst oxidase: comparison with nonphagocyte oxidases. J. Leukoc. Biol. 2004, 76 (4), 760-781.
4. Jeremy, J. Y.; Yim, A. P.; Wan, S.; Angelini, G. D. Oxidative stress, nitric oxide, and vascular disease. J. Card. Surg. 2002, 17 (4), 324-327.
5. Terada, L. S.; Guidot, D. M.; Leff, J. A.; Willingham, I. R.; Hanley, M. E.; Piermattei, D.; Repine, J. E. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc. Natl. Acad. Sci. USA 1992, 89 (8), 3362-3366.
6. Halliwell, B.; Gutteridge, J. M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990, 186, 1-85.
7. Halliwell, B.; Grootveld, M. The measurement of free radical reactions in humans. Some thoughts for future experimentation. FEBS Lett. 1987, 213 (1), 9-14.
8. Morrow, J. D.; Roberts, L. J. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am. J. Respir. Crit Care Med. 2002, 166 (12 Pt 2), S25-S30.
9. Schulz, R.; Mahmoudi, S.; Hattar, K.; Sibelius, U.; Olschewski, H.; Mayer, K.; Seeger, W.; Grimminger, F. Enhanced release of super-oxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am. J. Respir. Crit Care Med. 2000, 162 (2 Pt 1), 566-570.
10. Marshall, C.; Mamary, A. J.; Verhoeven, A. J.; Marshall, B. E. Pulmonary artery NADPH-oxidase is activated in hypoxic pulmonary vasoconstriction. Am. J. Respir. Cell Mol. Biol. 1996, 15 (5), 633-644.
11. Joyeux-Faure, M.; Stanke-Labesque, F.; Lefebvre, B.; Beguin, P.; Godin-Ribuot, D.; Ribuot, C.; Launois, S. H.; Bessard, G.; Levy, P. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J. Appl. Physiol. 2005, 98 (5), 1691-1696.
12. Suematsu, N.; Tsutsui, H.; Wen, J.; Kang, D.; Ikeuchi, M.; Ide, T.; Hayashidani, S.; Shiomi, T.; Kubota, T.; Hamasaki, N.; Takeshita, A. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 2003, 107 (10), 1418-1423.
13. Goldbart, A.; Row, B. W.; Kheirandish, L.; Schurr, A.; Gozal, E.; Guo, S. Z.; Payne, R. S.; Cheng, Z.; Brittian, K. R.; Gozal, D. Intermittent hypoxic exposure during light phase induces changes in cAMP response element binding protein activity in the rat CA1 hippocampal region: water maze performance correlates. Neuroscience 2003, 122 (3), 585-590.
14. Ozturk, H.; Gezici, A.; Ozturk, H. The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusion-induced oxidative stress in rats. Hepatol. Res. 2006, 34 (2), 76-83.
15. Corno, A. F.; Milano, G.; Morel, S.; Tozzi, P.; Genton, C. Y.; Samaja, M.; von Segesser, L. K. Hypoxia: unique myocardial morphology? J. Thorac. Cardiovasc. Surg. 2004, 127 (5), 1301-1308.
16. Shamsuzzaman, A. S.; Gersh, B. J.; Somers, V. K. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003, 290 (14), 1906-1914.
17. Dart, R. A.; Gregoire, J. R.; Gutterman, D. D.; Woolf, S. H. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing. Chest 2003, 123 (1), 244-260.
18. Shahar, E.; Whitney, C. W.; Redline, S.; Lee, E. T.; Newman, A. B.; Javier, N. F.; O'Connor, G. T.; Boland, L. L.; Schwartz, J. E.; Samet, J. M. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am. J. Respir. Crit Care Med. 2001, 163 (1), 19-25.
19. Fletcher, E. C.; Bao, G. The rat as a model of chronic recurrent episodic hypoxia and effect upon systemic blood pressure. Sleep 1996, 19 (10 Suppl.), S210-S212.
20. Fletcher, E. C.; Bao, G.; Miller, C. C. III Effect of recurrent episodic hypocapnic, eucapnic, and hypercapnic hypoxia on systemic blood pressure. J. Appl. Physiol. 1995, 78 (4), 1516-1521.
21. Touyz, R. M. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 2004, 44 (3), 248-252.
22. Redon, J.; Oliva, M. R.; Tormos, C.; Giner, V.; Chaves, J.; Iradi, A.; Saez, G. T. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension 2003, 41 (5), 1096-1101.
23. Rodriguez-Iturbe, B.; Zhan, C. D.; Quiroz, Y.; Sindhu, R. K.; Vaziri, N. D. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 2003, 41 (2), 341-346.
24. Engelhard, Y. N.; Gazer, B.; Paran, E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am. Heart J. 2006, 151 (1), 100.
25. Galun, E.; Axelrod, J. H. The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim. Biophys. Acta 2002, 1592 (3), 345-358.
26. Losser, M. R.; Payen, D. Mechanisms of liver damage. Semin. Liver Dis. 1996, 16 (4), 357-367.
27. Pietrangelo, A. Iron, oxidative stress and liver fibrogenesis. J. Hepatol. 1998, 28(Suppl. 1), 8-13.
28. Parola, M.; Robino, G. Oxidative stress-related molecules and liver fibrosis. J. Hepatol. 2001, 35 (2), 297-306.
29. Lander, H. M. An essential role for free radicals and derived species in signal transduction. FASEB J. 1997, 11 (2), 118-124.
30. Parola, M.; Bellomo, G.; Robino, G.; Barrera, G.; Dianzani, M. U. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid. Redox. Signal. 1999, 1 (3), 255-284.
31. Cadenas, E. Biochemistry of oxygen toxicity. Annu. Rev. Biochem. 1989, 58, 79-110.
32. Sies, H. Role of reactive oxygen species in biological processes. Klin. Wochenschr. 1991, 69 (21-23), 965-968.
33. Kaplowitz, N.; Tsukamoto, H. Oxidative stress and liver disease. Prog. Liver Dis. 1996, 14, 131-159.
34. Radi, R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 2004, 101 (12), 4003-4008.
35. Harbrecht, B. G.; Billiar, T. R.; Stadler, J.; Demetris, A. J.; Ochoa, J.; Curran, R. D.; Simmons, R. L. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury. J. Leukoc. Biol. 1992, 52 (4), 390-394.
36. Li, J.; Billiar, T. R. Nitric Oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am. J. Physiol 1999, 276 (5 Pt 1), G1069-G1073.
37. Grisham, M. B.; Jourd'Heuil, D.; Wink, D. A. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites:implications in inflammation. Am. J. Physiol. 1999, 276 (2 Pt 1), G315-G321.
38. Halliwell, B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994, 344 (8924), 721-724.
39. Marnett, L. J. Oxy radicals, lipid peroxidation and DNA damage. Toxicology 2002, 181-182, 219-222.
40. Spiteller, G. Are lipid peroxidation processes induced by changes in the cell wall structure and how are these processes connected with diseases? Med. Hypotheses 2003, 60 (1), 69-83.
41. Sevanian, A.; Hochstein, P. Mechanisms and consequences of lipid peroxidation in biological systems. Annu. Rev. Nutr. 1985, 5, 365-390.
42. Weber, L. W.; Boll, M.; Stampfl, A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev. Toxicol. 2003, 33 (2), 105-136.
43. Halliwell, B.; Chirico, S. Lipid peroxidation: its mechanism, measurement, and significance. Am. J. Clin. Nutr. 1993, 57(5 Suppl.), 715S-724S.
44. Tipoe, G. L.; Leung, T. M.; Liong, E.; So, H.; Leung, K. M.; Lau, T. Y.; Tom, W. M.; Fung, M. L.; Fan, S. T.; Nanji, A. A. Inhibitors of inducible nitric oxide (NO) synthase are more effective than an NO donor in reducing carbon-tetrachloride induced acute liver injury. Histol. Histopathol. 2006, 21 (11), 1157-1165.
45. Zhu, W.; Fung, P. C. The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl(4)-induced acute liver injury of mice. Free Radic. Biol. Med. 2000, 29 (9), 870-880.
46. Madamanchi, N. R.; Vendrov, A.; Runge, M. S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25 (1), 29-38.
47. Esper, R. J.; Nordaby, R. A.; Vilarino, J. O.; Paragano, A.; Cacharron, J. L.; Machado, R. A. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc. Diabetol. 2006, 5, 4.
48. Phillips, S. A.; Olson, E. B.; Morgan, B. J.; Lombard, J. H. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am. J. Physiol Heart Circ. Physiol. 2004, 286 (1), H388-H393.
49. Weyrich, A. S.; Ma, X. L.; Lefer, A. M. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992, 86 (1), 279-288.
50. Pabla, R.; Buda, A. J.; Flynn, D. M.; Blesse, S. A.; Shin, A. M.; Curtis, M. J.; Lefer, D. J. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ. Res. 1996, 78 (1), 65-72.
51. Cooke, J. P.; Tsao, P. S. Is NO an endogenous antiatherogenic molecule? Arterioscler. Thromb. 1994, 14 (5), 653-655.
52. Loscalzo, J.; Welch, G. Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis. 1995, 38 (2), 87-104.
53. Alioua, A.; Tanaka, Y.; Wallner, M.; Hofmann, F.; Ruth, P.; Meera, P.; Toro, L. The large conductance, voltage-dependent, and calcium-sensitive K+ channel, Hslo, is a target of cGMP-dependent protein kinase phosphorylation in vivo. J. Biol. Chem. 1998, 273 (49), 32950-32956.
54. Schmidt, H. H.; Lohmann, S. M.; Walter, U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta 1993, 1178 (2), 153-175.
55. Surks, H. K.; Mochizuki, N.; Kasai, Y.; Georgescu, S. P.; Tang, K. M.; Ito, M.; Lincoln, T. M.; Mendelsohn, M. E. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase Ialpha. Science 1999, 286 (5444), 1583-1587.
56. Beckman, J. S.; Koppenol, W. H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 1996, 271 (5 Pt 1), C1424-C1437.
57. Arndt, H.; Russell, J. B.; Kurose, I.; Kubes, P.; Granger, D. N. Mediators of leukocyte adhesion in rat mesenteric venules elicited by inhibition of nitric oxide synthesis. Gastroenterology 1993, 105 (3), 675-680.
58. Kubes, P.; Granger, D. N. Nitric oxide modulates microvascular permeability. Am. J. Physiol. 1992, 262 (2 Pt 2), H611-H615.
59. Koide, M.; Kawahara, Y.; Tsuda, T.; Yokoyama, M. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett. 1993, 318 (3), 213-217.
60. Chester, A. H.; Borland, J. A.; Buttery, L. D.; Mitchell, J. A.; Cunningham, D. A.; Hafizi, S.; Hoare, G. S.; Springall, D. R.; Polak, J. M.; Yacoub, M. H. Induction of nitric oxide synthase in human vascular smooth muscle: interactions between proinflammatory cytokines. Cardiovasc. Res. 1998, 38 (3), 814-821.
61. Stoclet, J. C.; Troncy, E.; Muller, B.; Brua, C.; Kleschyov, A. L. Molecular mechanisms underlying the role of nitric oxide in the cardiovascular system. Expert. Opin. Investig. Drugs 1998, 7 (11), 1769-1779.
62. Matthews, J. R.; Botting, C. H.; Panico, M.; Morris, H. R.; Hay, R. T. Inhibition of NF-kappaB DNA binding by nitric oxide. Nucleic Acids Res. 1996, 24 (12), 2236-2242.
63. Nikitovic, D.; Holmgren, A.; Spyrou, G. Inhibition of AP-1 DNA binding by nitric oxide involving conserved cysteine residues in Jun and Fos. Biochem. Biophys. Res. Commun. 1998, 242 (1), 109-112.
64. Gozal, E.; Row, B. W.; Schurr, A.; Gozal, D. Developmental differences in cortical and hippocampal vulnerability to intermittent hypoxia in the rat. Neurosci. Lett. 2001, 305 (3), 197-201.
65. Bauer, P. M.; Fukuto, J. M.; Buga, G. M.; Pegg, A. E.; Ignarro, L. J. Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. Biochem. Biophys. Res. Commun. 1999, 262 (2), 355-358.
66. Moncada, S.; Higgs, E. A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995, 9 (13), 1319-1330.
67. Cross, R. K.; Wilson, K. T. Nitric oxide in inflammatory bowel disease. Inflamm. Bowel. Dis. 2003, 9 (3), 179-189.
68. Pratico, D. Antioxidants and endothelium protection. Atherosclerosis 2005, 181 (2), 215-224.
69. Heitzer, T.; Just, H.; Munzel, T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996, 94 (1), 6-9.
70. Rodriguez-Porcel, M.; Lerman, L. O.; Holmes, D. j.; Richardson, D.; Napoli, C.; Lerman, A. Chronic antioxidant supplementation attenuates nuclear factor-kappa B activation and preserves endothelial function in hypercholesterolemic pigs. Cardiovasc. Res. 2002, 53 (4), 1010-1018.
71. Ting, H. H.; Timimi, F. K.; Haley, E. A.; Roddy, M. A.; Ganz, P.; Creager, M. A. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 1997, 95 (12), 2617-2622.
72. Timimi, F. K.; Ting, H. H.; Haley, E. A.; Roddy, M. A.; Ganz, P.; Creager, M. A. Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 1998, 31 (3), 552-557.
73. Entzian, P.; Linnemann, K.; Schlaak, M.; Zabel, P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am. J. Respir. Crit. Care Med. 1996, 153 (3), 1080-1086.
74. Arnould, T.; Michiels, C.; Remacle, J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. Am. J. Physiol. 1993, 264 (5 Pt 1), C1102-C1110.
75. Gerszten, R. E.; Garcia-Zepeda, E. A.; Lim, Y. C.; Yoshida, M.; Ding, H. A.; Gimbrone, M. A.; Jr.; Luster, A. D.; Luscinskas, F. W.; Rosenzweig, A. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999, 398 (6729), 718-723.
76. Hayden, M. S.; Ghosh, S. Signaling to NF-kappaB. Genes Dev. 2004, 18 (18), 2195-2224.
77. Yuan, G. J.; Zhou, X. R.; Gong, Z. J.; Zhang, P.; Sun, X. M.; Zheng, S. H. Expression and activity of inducible nitric oxide synthase and endothelial nitric oxide synthase correlate with ethanol-induced liver injury. World J. Gastroenterol. 2006, 12 (15), 2375-2381.
78. Zhou, L. Z.; Johnson, A. P.; Rando, T. A. NF kappa B and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic. Biol. Med. 2001, 31 (11), 1405-1416.
79. Banerjee, T.; Valacchi, G.; Ziboh, V. A.; van, d.; V Inhibition of TNFalpha-induced cyclooxygenase-2 expression by amentoflavone through suppression of NF-kappaB activation in A549 cells. Mol. Cell Biochem. 2002, 238 (1-2), 105-110.
80. Dyugovskaya, L.; Lavie, P.; Lavie, L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am. J. Respir. Crit. Care Med. 2002, 165 (7), 934-939.
81. Walzog, B.; Gaehtgens, P. Adhesion Molecules: The Path to a New Understanding of Acute Inflammation. News Physiol. Sci. 2000, 15, 107-113.
82. Lavie, L. Obstructive sleep apnoea syndrome - an oxidative stress disorder. Sleep Med. Rev. 2003, 7 (1), 35-51.
83. Grisham, M. B.; Granger, D. N.; Lefer, D. J. Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic. Biol. Med. 1998, 25 (4-5), 404-433.
84. Baker, S. J.; Reddy, E. P. Modulation of life and death by the TNF receptor superfamily. Oncogene 1998, 17 (25), 3261-3270.
85. Bossy-Wetzel, E.; Green, D. R. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J. Biol. Chem. 1999, 274 (25), 17484-17490.
86. Li, P.; Nijhawan, D.; Budihardjo, I.; Srinivasula, S. M.; Ahmad, M.; Alnemri, E. S.; Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91 (4), 479-489.
87. Park, G. Y.; Christman, J. W. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290 (5), L797-L805.
88. Matsuoka, T.; Hirata, M.; Tanaka, H.; Takahashi, Y.; Murata, T.; Kabashima, K.; Sugimoto, Y.; Kobayashi, T.; Ushikubi, F.; Aze, Y.; Eguchi, N.; Urade, Y.; Yoshida, N.; Kimura, K.; Mizoguchi, A.; Honda, Y.; Nagai, H.; Narumiya, S. Prostaglandin D2 as a mediator of allergic asthma. Science 2000, 287 (5460), 2013-2017.
89. Murata, T.; Ushikubi, F.; Matsuoka, T.; Hirata, M.; Yamasaki, A.; Sugimoto, Y.; Ichikawa, A.; Aze, Y.; Tanaka, T.; Yoshida, N.; Ueno, A.; Oh-ishi, S.; Narumiya, S. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 1997, 388 (6643), 678-682.
90. Nataraj, C.; Thomas, D. W.; Tilley, S. L.; Nguyen, M. T.; Mannon, R.; Koller, B. H.; Coffman, T. M. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J. Clin. Invest. 2001, 108 (8), 1229-1235.
91. Takahashi, Y.; Tokuoka, S.; Masuda, T.; Hirano, Y.; Nagao, M.; Tanaka, H.; Inagaki, N.; Narumiya, S.; Nagai, H. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 2002, 137 (3), 315-322.
92. Aneja, R.; Hake, P. W.; Burroughs, T. J.; Denenberg, A. G.; Wong, H. R.; Zingarelli, B. Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol. Med. 2004, 10 (1-6), 55-62.
93. Yumei, F.; Zhou, Y.; Zheng, S.; Chen, A. The antifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells. Lab Invest. 2006, 86 (7), 697-709.
94. Giakoustidis, A. E.; Giakoustidis, D. E.; Iliadis, S.; Papageorgiou, G.; Koliakou, K.; Kontos, N.; Taitzoglou, I.; Botsoglou, E.; Papanikolaou, V.; Atmatzidis, K.; Takoudas, D.; Antoniadis, A. Attenuation of intestinal ischemia/reperfusion induced liver and lung injury by intraperitoneal administration of (-)-epigallocatechin-3-gallate. Free Radic. Res. 2006, 40 (1), 103-110.
95. Tang, W. J.; Hu, C. P.; Chen, M. F.; Deng, P. Y.; Li, Y. J. Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can. J. Physiol. Pharmacol. 2006, 84 (2), 163-171.
96. Forde, P.; Scribner, A. W.; Dial, R.; Loscalzo, J.; Trolliet, M. R. Prevention of hypertension and renal dysfunction in Dahl rats by alpha-tocopherol. J. Cardiovasc. Pharmacol. 2003, 42 (1), 82-88.
97. Bohm, F.; Settergren, M.; Pernow, J. Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo. Atherosclerosis 2007, 190 (2), 108-15.
98. Grebe, M.; Eisele, H. J.; Weissmann, N.; Schaefer, C.; Tillmanns, H.; Seeger, W.; Schulz, R. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am. J. Respir. Crit. Care Med. 2006, 173 (8), 897-901.
99. Christou, K.; Moulas, A. N.; Pastaka, C.; Gourgoulianis, K. I. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med. 2003, 4 (3), 225-228.
100. Dona, M.; Dell'Aica, I.; Calabrese, F.; Benelli, R.; Morini, M.; Albini, A.; Garbisa, S. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol. 2003, 170 (8), 4335-4341.
101. Han, C. Screening of anticarcinogenic ingredients in tea polyphenols. Cancer Lett. 1997, 114 (1-2), 153-158.
102. Le, B. M.; Clement, M. V.; Pervaiz, S.; Brenner, C. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol. Histopathol. 2005, 20 (1), 205-219.
103. Michiels, C.; Raes, M.; Toussaint, O.; Remacle, J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic. Biol. Med. 1994, 17 (3), 235-248.
104. Wu, C. C.; Hsu, M. C.; Hsieh, C. W.; Lin, J. B.; Lai, P. H.; Wung, B. S. Upregulation of heme oxygenase-1 by Epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci. 2006, 78 (25), 2889-2897.
105. Clark, J. E.; Foresti, R.; Green, C. J.; Motterlini, R. Dynamics of haem oxygenase-1 expression and bilirubin production in cellular protection against oxidative stress. Biochem. J. 2000, 348 Pt 3, 615-619.
106. Lorenz, M.; Wessler, S.; Follmann, E.; Michaelis, W.; Dusterhoft, T.; Baumann, G.; Stangl, K.; Stangl, V. A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J. Biol. Chem. 2004, 279 (7), 6190-6195.
107. Frei, B.; Higdon, J. V. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J. Nutr. 2003, 133 (10), 3275S-3284S.
108. Salah, N.; Miller, N. J.; Paganga, G.; Tijburg, L.; Bolwell, G. P.; Rice-Evans, C. Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophys. 1995, 322 (2), 339-346.
109. Surh, Y. J.; Chun, K. S.; Cha, H. H.; Han, S. S.; Keum, Y. S.; Park, K. K.; Lee, S. S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: downregulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 2001, 480-481, 243-268.
110. Aucamp, J.; Gaspar, A.; Hara, Y.; Apostolides, Z. Inhibition of xanthine oxidase by catechins from tea (Camellia sinensis). Anticancer Res. 1997, 17 (6D), 4381-4385.
111. Khan, S. G.; Katiyar, S. K.; Agarwal, R.; Mukhtar, H. Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention. Cancer Res. 1992, 52 (14), 4050-4052.
112. Calo, L. A.; Davis, P. A.; Piccoli, A.; Pessina, A. C. A role for heme oxygenase-1 in the antioxidant and antiapoptotic effects of erythropoietin: the start of a good news/bad news story? Nephron Physiol. 2006, 103 (3), 107-111.
113. Graham, H. N. Green tea composition, consumption, and polyphenol chemistry. Prev. Med. 1992, 21 (3), 334-350.
114. Mukhtar, H.; Katiyar, S. K.; Agarwal, R. Green tea and skin - anticarcinogenic effects. J. Invest. Dermatol. 1994, 102 (1), 3-7.
115. Fujiki, H.; Suganuma, M.; Okabe, S.; Komori, A.; Sueoka, E.; Sueoka, N.; Kozu, T.; Sakai, Y. Japanese green tea as a cancer preventive in humans. Nutr. Rev. 1996, 54 (11 Pt 2), S67-S70.
116. Conney, A. H.; Lou, Y. R.; Xie, J. G.; Osawa, T.; Newmark, H. L.; Liu, Y.; Chang, R. L.; Huang, M. T. Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea. Proc. Soc. Exp. Biol. Med. 1997, 216 (2), 234-245.
117. Komori, A.; Yatsunami, J.; Okabe, S.; Abe, S.; Hara, K.; Suganuma, M.; Kim, S. J.; Fujiki, H. Anticarcinogenic activity of green tea polyphenols. Jpn. J. Clin. Oncol. 1993, 23 (3), 186-190.
118. Kato, T.; Harashima, T.; Moriya, N.; Kikugawa, K.; Hiramoto, K. Formation of the mutagenic/carcinogenic imidazoquinoxaline-type heterocyclic amines through the unstable free radical Maillard intermediates and its inhibition by phenolic antioxidants. Carcinogenesis 1996, 17 (11), 2469-2476.
119. Guo, Q.; Zhao, B.; Shen, S.; Hou, J.; Hu, J.; Xin, W. ESR study on the structure-antioxidant activity relationship of tea catechins and their epimers. Biochim. Biophys. Acta 1999, 1427 (1), 13-23.
120. Fiala, E. S.; Sodum, R. S.; Bhattacharya, M.; Li, H. (-)- Epigallocatechin gallate, a polyphenolic tea antioxidant, inhibits peroxynitrite-mediated formation of 8-oxodeoxyguanosine and 3-nitrotyrosine. Experientia 1996, 52 (9), 922-926.
121. Xu, Y.; Ho, C. T.; Amin, S. G.; Han, C.; Chung, F. L. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants. Cancer Res. 1992, 52 (14), 3875-3879.
122. Sai-Kato, K.; Umemura, T.; Takagi, A.; Hasegawa, R.; Tanimura, A.; Kurokawa, Y. Pentachlorophenol-induced oxidative DNA damage in mouse liver and protective effect of antioxidants. Food Chem. Toxicol. 1995, 33 (10), 877-882.
123. Wei, H.; Zhang, X.; Zhao, J. F.; Wang, Z. Y.; Bickers, D.; Lebwohl, M. Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teas. Free Radic. Biol. Med. 1999, 26 (11-12), 1427-1435.
124. Ishikawa, T.; Suzukawa, M.; Ito, T.; Yoshida, H.; Ayaori, M.; Nishiwaki, M.; Yonemura, A.; Hara, Y.; Nakamura, H. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin. Nutr. 1997, 66 (2), 261-266.
125. Miura, S.; Watanabe, J.; Sano, M.; Tomita, T.; Osawa, T.; Hara, Y.; Tomita, I. Effects of various natural antioxidants on the Cu(2+)-mediated oxidative modification of low density lipoprotein. Biol. Pharm. Bull. 1995, 18 (1), 1-4.
126. Lin, Y. L.; Lin, J. K. (-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol. Pharmacol. 1997, 52 (3), 465-472.
127. Chan, M. M.; Fong, D.; Ho, C. T.; Huang, H. I. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem. Pharmacol. 1997, 54 (12), 1281-1286.
128. Pannala, A. S.; Rice-Evans, C. A.; Halliwell, B.; Singh, S. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem. Biophys. Res. Commun. 1997, 232 (1), 164-168.
129. Hu, K. Q. Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases. Prostaglandins Leukot. Essent. Fatty Acids 2003, 69 (5), 329-337.
130. Hussain, T.; Gupta, S.; Adhami, V. M.; Mukhtar, H. Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int. J. Cancer 2005, 113 (4), 660-669.
131. Peng, G.; Dixon, D. A.; Muga, S. J.; Smith, T. J.; Wargovich, M. J. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol. Carcinog. 2006, 45 (5), 309-319.
132. Kundu, J. K.; Na, H. K.; Chun, K. S.; Kim, Y. K.; Lee, S. J.; Lee, S. S.; Lee, O. S.; Sim, Y. C.; Surh, Y. J. Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J. Nutr. 2003, 133 (11 Suppl. 1), 3805S-3810S.
133. Chen, J. H.; Tipoe, G. L.; Liong, E. C.; So, H. S.; Leung, K. M.; Tom, W. M.; Fung, P. C.; Nanji, A. A. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. Am. J. Clin. Nutr. 2004, 80 (3), 742-751.
134. Aktas, O.; Prozorovski, T.; Smorodchenko, A.; Savaskan, N. E.; Lauster, R.; Kloetzel, P. M.; Infante-Duarte, C.; Brocke, S.; Zipp, F. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J. Immunol. 2004, 173 (9), 5794-5800.
135. Yang, F.; Oz, H. S.; Barve, S.; de Villiers, W. J.; McClain, C. J.; Varilek, G. W. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 2001, 60 (3), 528-533.
136. D'Acquisto, F.; Iuvone, T.; Rombola, L.; Sautebin, L.; Di, R. M.; Carnuccio, R. Involvement of NF-kappaB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages. FEBS Lett. 1997, 418 (1-2), 175-178.
137. Haenen, G. R.; Paquay, J. B.; Korthouwer, R. E.; Bast, A. Peroxynitrite scavenging by flavonoids. Biochem. Biophys. Res. Commun. 1997, 236 (3), 591-593.
138. Nanjo, F.; Honda, M.; Okushio, K.; Matsumoto, N.; Ishigaki, F.; Ishigami, T.; Hara, Y. Effects of dietary tea catechins on alpha-tocopherol levels, lipid peroxidation, and erythrocyte deformability in rats fed on high palm oil and perilla oil diets. Biol. Pharm. Bull. 1993, 16 (11), 1156-1159.
139. Nakagawa, T.; Yokozawa, T. Direct scavenging of nitric oxide and superoxide by green tea. Food Chem. Toxicol. 2002, 40 (12), 1745-1750.
140. Paquay, J. B.; Haenen, G. R.; Stender, G.; Wiseman, S. A.; Tijburg, L. B.; Bast, A. Protection against nitric oxide toxicity by tea. J. Agric. Food Chem. 2000, 48 (11), 5768-5772.
141. Huang, Y.; Zhang, A.; Lau, C. W.; Chen, Z. Y. Vasorelaxant effects of purified green tea epicatechin derivatives in rat mesenteric artery. Life Sci. 1998, 63 (4), 275-283.
142. Alvarez, E.; Campos-Toimil, M.; Justiniano-Basaran, H.; Lugnier, C.; Orallo, F. Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta. Br. J. Pharmacol. 2006, 147 (3), 269-280.
143. Angel, P.; Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1991, 1072 (2-3), 129-157.
144. Wisdom, R. AP-1: one switch for many signals. Exp. Cell Res. 1999, 253 (1), 180-185.
145. Hoffmann, A.; Gloe, T.; Pohl, U. Hypoxia-induced upregulation of eNOS gene expression is redox-sensitive: a comparison between hypoxia and inhibitors of cell metabolism. J. Cell Physiol. 2001, 188 (1), 33-44.
146. Dong, Z.; Ma, W.; Huang, C.; Yang, C. S. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. Cancer Res. 1997, 57 (19), 4414-4419.
147. Chung, J. Y.; Huang, C.; Meng, X.; Dong, Z.; Yang, C. S. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. Cancer Res. 1999, 59 (18), 4610-4617.
148. Furchgott, R. F. Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci. Rep. 1999, 19 (4), 235-251.